95 related articles for article (PubMed ID: 25813993)
1. Tumor Regression After Brachytherapy for Choroidal Melanoma: Reduction of Thickness and Cross-Sectional Area by Shape and Regression Pattern.
Rashid M; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2612-23. PubMed ID: 25813993
[TBL] [Abstract][Full Text] [Related]
2. Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model.
Rashid M; Heikkonen J; Singh AD; Kivelä TT
Ophthalmology; 2018 May; 125(5):747-754. PubMed ID: 29499831
[TBL] [Abstract][Full Text] [Related]
3. Ocular response of choroidal melanoma with monosomy 3 versus disomy 3 after iodine-125 brachytherapy.
Marathe OS; Wu J; Lee SP; Yu F; Burgess BL; Leu M; Straatsma BR; McCannel TA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1046-8. PubMed ID: 20932685
[TBL] [Abstract][Full Text] [Related]
4. Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy?
Chiam PJ; Coupland SE; Kalirai H; Groenewald C; Heimann H; Damato BE
Br J Ophthalmol; 2014 Jul; 98(7):967-71. PubMed ID: 24518077
[TBL] [Abstract][Full Text] [Related]
5. Multi-year follow-up of fine-needle aspiration biopsy in choroidal melanoma.
McCannel TA; Chang MY; Burgess BL
Ophthalmology; 2012 Mar; 119(3):606-10. PubMed ID: 22226884
[TBL] [Abstract][Full Text] [Related]
6. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
7. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
[TBL] [Abstract][Full Text] [Related]
8. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
Finger PT; Chin KJ; Tena LB
Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of choroidal melanomas treated with eye physics: a 20-year review.
Berry JL; Dandapani SV; Stevanovic M; Lee TC; Astrahan M; Murphree AL; Kim JW
JAMA Ophthalmol; 2013 Nov; 131(11):1435-42. PubMed ID: 24008431
[TBL] [Abstract][Full Text] [Related]
10. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
Semenova E; Finger PT
JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
[TBL] [Abstract][Full Text] [Related]
11. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
Stoffelns BM; Kutzner J; Jochem T
Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
[TBL] [Abstract][Full Text] [Related]
12. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
14. [Tumor regression in malignant choroidal melanomas after transpupillary thermotherapy (TTT) versus ruthenium brachytherapy and sandwich therapy - a comparative analysis].
Stoffelns BM; Schoepfer K; Jochem T; Faldum A
Klin Monbl Augenheilkd; 2010 Apr; 227(4):262-8. PubMed ID: 20408070
[TBL] [Abstract][Full Text] [Related]
15. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
[TBL] [Abstract][Full Text] [Related]
16. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
17. 125I plaque brachytherapy for anterior uveal melanomas.
Lumbroso-Le Rouic L; Charif Chefchaouni M; Levy C; Plancher C; Dendale R; Asselain B; Solignac S; Mazal A; Desjardins L
Eye (Lond); 2004 Sep; 18(9):911-6. PubMed ID: 15002010
[TBL] [Abstract][Full Text] [Related]
18. Management of choroidal melanomas less than 10 mm in largest basal diameter with a 10-mm ruthenium plaque.
Salkola S; Heikkonen J; Eskelin S; Kivelä T
Retina; 2014 Oct; 34(10):2110-20. PubMed ID: 24978431
[TBL] [Abstract][Full Text] [Related]
19. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
[TBL] [Abstract][Full Text] [Related]
20. [Iodine-125-brachytherapy of malignant choroid melanoma. II: Long-term functional outcome].
Kreissig I; Rose D; Simader E
Klin Monbl Augenheilkd; 1996 Jul; 209(1):7-12. PubMed ID: 8965481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]